弥合C型肝炎护理差距:在加拿大安大略省实现世界卫生组织目标的建模方法
Yeva Sahakyan1, Aysegul Erman1,2, William W L Wong1,2,3
1Toronto Health Economics and Technology Assessment Collaborative (THETA), University Health Network, Toronto, ON M5G 2C4, Canada.
为了实现世界卫生组织的C型肝炎病毒 (HCV) 消除目标,扩大RNA测试和治疗是至关重要的. 双重抗体检测可能会在2035年实现死亡率目标,而不是2030年,但仍然具有成本效益.
科学领域:
- 肝病学和传染病的研究
- 公共卫生政策 公共卫生政策
- 卫生经济学 卫生经济学
背景情况:
- 世界卫生组织 (WHO) 已经制定了2030年消除C型肝炎病毒 (HCV) 的目标.
- 识别HCV护理级联中的差距对于实现这些目标至关重要.
- 本研究评估了在加拿大安大略省实现世卫组织HCV消除目标所需的服务扩展.
研究的目的:
- 确定在HCV护理级联中必要的服务扩展,以实现世卫组织在安大略省的HCV消除目标.
- 预测安大略省与HCV相关的质量调整寿命年 (QALY) 和医疗保健成本.
主要方法:
- 使用决策分析模型预测了安大略省HCV患者的QALY和医疗费用.
- RNA测试和治疗率提高到98%.
- 增加了抗体测试的使用量,以实现世卫组织2030年减少死亡率的目标.
主要成果:
- 在没有扩大规模的情况下,预计QALY和人均成本分别为9.156加元和48,996加元.
- 增加RNA测试和治疗将与肝脏相关的死亡减少了57% (至3.3/100,000).
- 将抗体检测率翻一番可以在2035年之前实现世卫组织的死亡率目标,但不能在2030年之前实现.
结论:
- 增加RNA检测和治疗,加上抗体检测率翻倍,显示出在2035年前实现世卫组织目标的潜力.
- 如果每年实施成本低于2.3M CAD/100,000人,则干预措施在获得的50,000 CAD/QALY门内具有成本效益.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
相关概念视频
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
